These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 26622591)

  • 1. Downregulated expression of PHLDA1 protein is associated with a malignant phenotype of cholangiocarcinoma.
    Zhao PO; Li X; Lu Y; Liu L
    Oncol Lett; 2015 Aug; 10(2):895-900. PubMed ID: 26622591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased expression of TFPI-2 correlated with increased expression of CD133 in cholangiocarcinoma.
    Chu X; Zhao P; Lv Y; Liu L
    Int J Clin Exp Pathol; 2015; 8(1):328-36. PubMed ID: 25755719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of decreased expression of PHLDA1 protein with malignant phenotype of gastric adenocarcinoma.
    Zhao P; Lu Y; Liu L
    Int J Clin Exp Pathol; 2015; 8(5):5230-5. PubMed ID: 26191222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of PHLDA1 gene expression is associated with breast cancer progression.
    Nagai MA; Fregnani JH; Netto MM; Brentani MM; Soares FA
    Breast Cancer Res Treat; 2007 Nov; 106(1):49-56. PubMed ID: 17211533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inverse correlation of aberrant expression of fragile histidine triad (FHIT) protein with cyclin D1 protein and prognosis in Chinese patients with cholangiocarcinoma.
    Zhao P; Lu Y; Zhong M; Liu L; Li B
    Acta Oncol; 2008; 47(8):1557-63. PubMed ID: 18618300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PHLDA1 (pleckstrin homology-like domain, family A, member 1) knockdown promotes migration and invasion of MCF10A breast epithelial cells.
    Bonatto N; Carlini MJ; de Bessa Garcia SA; Nagai MA
    Cell Adh Migr; 2018 Jan; 12(1):37-46. PubMed ID: 28640659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pleckstrin homology-like domain, family A, member 1 (
    Nagai MA
    Biomed Rep; 2016 Mar; 4(3):275-281. PubMed ID: 26998263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PHLDA1 expression in ulcerative colitis: A potential role in the management of dysplasia.
    Orita F; Ishikawa T; Ishiguro M; Okazaki S; Kikuchi A; Yamauchi S; Matsuyama T; Tokunaga M; Uetake H; Kinugasa Y
    Mol Clin Oncol; 2021 Sep; 15(3):192. PubMed ID: 34349991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of c-erbB-2 proto-oncogene in extrahepatic cholangiocarcinoma and its clinical significance.
    Zheng J; Zhu YM
    Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):412-5. PubMed ID: 17690040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation-related DNA damage and expression of CD133 and Oct3/4 in cholangiocarcinoma patients with poor prognosis.
    Thanan R; Pairojkul C; Pinlaor S; Khuntikeo N; Wongkham C; Sripa B; Ma N; Vaeteewoottacharn K; Furukawa A; Kobayashi H; Hiraku Y; Oikawa S; Kawanishi S; Yongvanit P; Murata M
    Free Radic Biol Med; 2013 Dec; 65():1464-1472. PubMed ID: 23917144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression patterns and prognostic significance of pleckstrin homology-like domain family A (PHLDA) in lung cancer and malignant mesothelioma.
    Baldavira CM; Machado-Rugolo J; Prieto TG; Bastos DR; Balancin M; Ab'Saber AM; Yaegashi LB; Souza PC; Farhat C; Takagaki TY; Nagai MA; Capelozzi VL
    J Thorac Dis; 2021 Feb; 13(2):689-707. PubMed ID: 33717542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of CIP2A in cholangiocarcinoma and correlation with poor prognosis.
    Xu P; Huang Q; Xie F; Xu XL; Shao F
    Hepatogastroenterology; 2013 Jun; 60(124):669-72. PubMed ID: 24046827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different expression of glucose transporters in the progression of intrahepatic cholangiocarcinoma.
    Kubo Y; Aishima S; Tanaka Y; Shindo K; Mizuuchi Y; Abe K; Shirabe K; Maehara Y; Honda H; Oda Y
    Hum Pathol; 2014 Aug; 45(8):1610-7. PubMed ID: 24824030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PHLDA1 Modulates the Endoplasmic Reticulum Stress Response and is required for Resistance to Oxidative Stress-induced Cell Death in Human Ovarian Cancer Cells.
    Xu J; Bi G; Luo Q; Liu Y; Liu T; Li L; Zeng Q; Wang Q; Wang Y; Yu J; Yi P
    J Cancer; 2021; 12(18):5486-5493. PubMed ID: 34405011
    [No Abstract]   [Full Text] [Related]  

  • 15. Downregulation of the PHLDA1 gene in IMR-32 neuroblastoma cells increases levels of Aurora A, TRKB and affects proteins involved in apoptosis and autophagy pathways.
    Durbas M; Horwacik I; Boratyn E; Rokita H
    Int J Oncol; 2016 Aug; 49(2):823-37. PubMed ID: 27278006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follicular stem cell marker PHLDA1 (TDAG51) is superior to cytokeratin-20 in differentiating between trichoepithelioma and basal cell carcinoma in small biopsy specimens.
    Sellheyer K; Nelson P
    J Cutan Pathol; 2011 Jul; 38(7):542-50. PubMed ID: 21352265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-mobility group AT-hook 2: an independent marker of poor prognosis in intrahepatic cholangiocarcinoma.
    Lee CT; Wu TT; Lohse CM; Zhang L
    Hum Pathol; 2014 Nov; 45(11):2334-40. PubMed ID: 25245603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
    Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
    Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated AQP1 Expression Is Associated With Unfavorable Oncologic Outcome in Patients With Hilar Cholangiocarcinoma.
    Li C; Li X; Wu L; Jiang Z
    Technol Cancer Res Treat; 2017 Aug; 16(4):421-427. PubMed ID: 27143047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological correlates of aspartyl (asparaginyl) beta-hydroxylase over-expression in cholangiocarcinoma.
    Maeda T; Taguchi K; Aishima S; Shimada M; Hintz D; Larusso N; Gores G; Tsuneyoshi M; Sugimachi K; Wands JR; de la Monte SM
    Cancer Detect Prev; 2004; 28(5):313-8. PubMed ID: 15542253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.